05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
The Internal Revenue Service and the Social Security Administration have announced the cost of livin...
Read More >
Dear YouDig?, Seriously, we run into contractors that will lie, lie, lie and then after taking a br...
Read More >
NEW JERSEY - On 13 May 2020 Governor Murphy issued Executive Order No. 142 (E.O. 142) permitting non...
Read More >
Bill 108, the More Homes, More Choice Act, received Royal Assent on June 6, 2019. The Act amended 13...
Read More >
Seyfarth Synopsis: Two new Executive Orders and a corresponding decision in the Supreme Court effect...
Read More >
Von Kaenel v. Armstrong Teasdale, LLP, No. 18-2850 (8th Cir. 2019) The question whether an individu...
Read More >